Metabolic & Cardiometabolic
Part of Biotech - Drug Development
| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
 LLY | Eli Lilly & Co. | $1.0t | $1123.00 | -0.2% | 4.1M |
 AZN | AstraZeneca PLC | $287.9b | $185.08 | +1.8% | 2.3M |
 MDGL | Madrigal Pharmaceuticals, Inc. Common Stock | $11.5b | $486.98 | -1.2% | 187.1K |
 PTGX | Protagonist Therapeutics, Inc | $6.4b | $97.33 | -5.3% | 887.4K |
 TERN | Terns Pharmaceuticals, Inc. Common Stock | $6.1b | $52.97 | +0.0% | 2.3M |
 TVTX | Travere Therapeutics, Inc. Common Stock | $4.4b | $45.78 | -0.9% | 2.9M |
 NAMS | NewAmsterdam Pharma Company N.V. Ordinary Shares | $3.9b | $31.48 | -3.6% | 1.1M |
 VKTX | Viking Therapeutics, Inc | $3.8b | $28.45 | -4.5% | 2.7M |
 KNSA | Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares | $3.7b | $48.37 | -1.8% | 344.6K |
 MLYS | Mineralys Therapeutics, Inc. Common Stock | $2.6b | $23.71 | -5.3% | 4.2M |
 MBX | MBX Biosciences, Inc. Common Stock | $1.5b | $30.27 | -2.1% | 580.4K |
 MAZE | Maze Therapeutics, Inc. Common Stock | $1.5b | $24.25 | -4.5% | 445.6K |
 SEPN | Septerna, Inc. Common Stock | $1.4b | $31.19 | -0.6% | 211.7K |
 MNKD | Mannkind Corporation | $1.2b | $3.40 | -3.4% | 3.2M |
 LXRX | Lexicon Pharmaceuticals, Inc. | $1.0b | $1.91 | +0.5% | 1.8M |
 ESPR | Esperion Therapeutics, Inc. | $0.8b | $3.13 | 0.0% | 8.4M |
 BIOA | BioAge Labs, Inc. Common Stock | $0.8b | $15.67 | -7.9% | 376.3K |
 ALT | Altimmune, Inc. Common Stock | $0.6b | $2.71 | -7.4% | 3.1M |
 GYRE | Gyre Therapeutics, Inc. Common Stock | $0.6b | $6.31 | +1.9% | 137.9K |
 SGMT | Sagimet Biosciences Inc. Series A Common Stock | $450.2m | $6.76 | -4.3% | 608.3K |
 RZLT | Rezolute, Inc. Common Stock (NV) | $317.8m | $4.25 | -5.8% | 2.1M |
 TENX | Tenax Therapeutics, Inc. | $314.9m | $10.73 | -3.2% | 560.4K |
 MIST | Milestone Pharmaceuticals Inc. Common Shares | $176.8m | $1.23 | -5.0% | 2.4M |
 ORMP | Oramed Pharmaceuticals Inc. | $162.5m | $3.71 | -2.5% | 99.8K |
 CRDL | Cardiol Therapeutics Inc. Class A Common Shares | $140.6m | $1.12 | -2.6% | 427.4K |
 VTVT | vTv Therapeutics Inc. Class A Common Stock | $131.4m | $32.17 | -6.3% | 40.0K |
 GUTS | Fractyl Health, Inc. Common Stock | $127.9m | $0.68 | -7.2% | 2.9M |
 VANI | Vivani Medical, Inc. Common Stock (DE) | $113.8m | $1.17 | -8.6% | 157.3K |
 BMEA | Biomea Fusion, Inc. Common Stock | $99.8m | $1.27 | -7.3% | 1.4M |
 AARD | Aardvark Therapeutics, Inc. Common Stock | $89.7m | $3.67 | -6.8% | 139.9K |
 VERU | Veru Inc. | $38.0m | $3.39 | -19.9% | 10.8M |
 GRDX | GridAI Technologies Corp. Common Stock | $37.3m | $6.34 | +4.6% | 121.4K |
 ALGS | Aligos Therapeutics, Inc. Common Stock | $35.3m | $4.92 | -7.9% | 128.4K |
 SKYE | Skye Bioscience, Inc. Common Stock | $27.3m | $0.73 | -5.2% | 170.2K |
 NCEL | NewcelX Ltd. Ordinary Shares | $19.0m | $3.24 | +2.9% | 17.2K |
 LPCN | Lipocine Inc. | $18.5m | $2.07 | -6.3% | 87.6K |
 CVKD | Cadrenal Therapeutics, Inc. Common Stock | $15.3m | $4.36 | +1.0% | 58.9K |
 MTVA | MetaVia Inc. Common Stock | $14.7m | $2.58 | +5.3% | 16.0M |
 CURX | Curanex Pharmaceuticals Inc Common Stock | $9.4m | $0.32 | -3.8% | 111.4K |
 ELAB | PMGC Holdings Inc. Common Stock | $8.0m | $1.55 | -8.3% | 765.1K |
 TCRT | Alaunos Therapeutics, Inc. Common Stock | $7.0m | $2.33 | -4.5% | 42.6K |
 GLMD | Galmed Pharmaceuticals Ltd. | $5.0m | $0.69 | -4.8% | 121.7K |